Ligand validation:8ICX

TTP: THYMIDINE-5'-TRIPHOSPHATE

TTP is a Ligand Of Interest in 8ICX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ICX_TTP_A_338	18%	40%	0.234	0.877	0.91	1.41	-	1	4	0	69%	0.3448
5VRY_TTP_P_101	91%	26%	0.08	0.968	1.16	1.83	4	8	0	0	100%	0.85
5VS3_TTP_P_101	89%	19%	0.099	0.977	1.13	2.29	3	9	0	0	100%	0.2
5VRZ_TTP_P_101	86%	22%	0.102	0.971	1.28	1.96	5	8	3	0	100%	0.2
5VRX_TTP_P_103	81%	12%	0.122	0.976	1.34	2.66	5	15	2	0	100%	1
5VS2_TTP_A_401	70%	19%	0.144	0.961	1.31	2.13	4	8	0	0	100%	1
1T3N_TTP_B_902	100%	1%	0.032	0.993	5.38	2.52	12	15	2	0	100%	0.5
2QXX_TTP_B_201	98%	26%	0.064	0.986	1.25	1.75	4	7	2	0	100%	1
3O0Q_TTP_A_1001	98%	23%	0.058	0.978	1.23	1.9	3	9	1	0	100%	1
1W4R_TTP_G_300	97%	14%	0.073	0.986	2.02	1.88	7	11	1	0	100%	0.6
6B5K_TTP_A_301	96%	21%	0.08	0.988	1.34	1.93	2	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.